Cardiovascular Systems Inc

2023 Q1 Form 10-Q Financial Statement

#000118014523000016 Filed on February 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4

Balance Sheet

Concept 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $129.5M
YoY Change -25.63%
Cash & Equivalents $59.84M
Short-Term Investments $69.69M
Other Short-Term Assets $8.535M
YoY Change 76.27%
Inventory $41.19M
Prepaid Expenses
Receivables $40.23M
Other Receivables $0.00
Total Short-Term Assets $222.0M
YoY Change -10.5%
LONG-TERM ASSETS
Property, Plant & Equipment $30.00M
YoY Change 2.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $42.03M
YoY Change 41.69%
Other Assets $2.467M
YoY Change -15.34%
Total Long-Term Assets $89.55M
YoY Change 14.21%
TOTAL ASSETS
Total Short-Term Assets $222.0M
Total Long-Term Assets $89.55M
Total Assets $311.5M
YoY Change -4.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.09M
YoY Change 36.77%
Accrued Expenses $19.15M
YoY Change -28.19%
Deferred Revenue $991.0K
YoY Change -12.22%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $36.76M
YoY Change -12.22%
LONG-TERM LIABILITIES
Long-Term Debt $20.12M
YoY Change -1.66%
Other Long-Term Liabilities $11.87M
YoY Change 213.55%
Total Long-Term Liabilities $11.87M
YoY Change 213.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $36.76M
Total Long-Term Liabilities $11.87M
Total Liabilities $72.12M
YoY Change 7.84%
SHAREHOLDERS EQUITY
Retained Earnings -$443.4M
YoY Change 9.72%
Common Stock $683.0M
YoY Change 2.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $239.4M
YoY Change
Total Liabilities & Shareholders Equity $311.5M
YoY Change -4.56%

Cashflow Statement

Concept 2023 Q1 2022 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001180145
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52082
dei Entity Registrant Name
EntityRegistrantName
CARDIOVASCULAR SYSTEMS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1698056
dei Entity Address Address Line1
EntityAddressAddressLine1
1225 Old Highway 8 Northwest
dei Entity Address City Or Town
EntityAddressCityOrTown
St. Paul
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55112-6416
dei City Area Code
CityAreaCode
651
dei Local Phone Number
LocalPhoneNumber
259-1600
dei Security12b Title
Security12bTitle
Common Stock, One-tenth of One Cent ($0.001) Par Value Per Share
dei Trading Symbol
TradingSymbol
CSII
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
41958938 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59843000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66424000 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
72159000 usd
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
93409000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40232000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39678000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
41191000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
34567000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8535000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7768000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
221960000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
241846000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30002000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29035000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15043000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15734000 usd
CY2022Q4 csii Strategic Investments
StrategicInvestments
42034000 usd
CY2022Q2 csii Strategic Investments
StrategicInvestments
33425000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2467000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2637000 usd
CY2022Q4 us-gaap Assets
Assets
311506000 usd
CY2022Q2 us-gaap Assets
Assets
322677000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
17087000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
14383000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19149000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23464000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
525000 usd
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2107000 usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41965948 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36761000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
39954000 usd
CY2022Q4 csii Financing Obligation Long Term
FinancingObligationLongTerm
20117000 usd
CY2022Q2 csii Financing Obligation Long Term
FinancingObligationLongTerm
20298000 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3365000 usd
CY2022Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11874000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12945000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
72117000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
73197000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41965948 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40965202 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40965202 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
40000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
40000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
682932000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
673388000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-170000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-268000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-443413000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-423680000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
239389000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
249480000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
311506000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
322677000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61453000 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59135000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121126000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117505000 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
18461000 usd
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
18073000 usd
us-gaap Cost Of Revenue
CostOfRevenue
35159000 usd
us-gaap Cost Of Revenue
CostOfRevenue
32381000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
42992000 usd
CY2021Q4 us-gaap Gross Profit
GrossProfit
41062000 usd
us-gaap Gross Profit
GrossProfit
85967000 usd
us-gaap Gross Profit
GrossProfit
85124000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41642000 usd
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
40402000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86117000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
82253000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9533000 usd
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8873000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18589000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18895000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
345000 usd
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
346000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
691000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
650000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
51520000 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
49621000 usd
us-gaap Operating Expenses
OperatingExpenses
105397000 usd
us-gaap Operating Expenses
OperatingExpenses
101798000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-8528000 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-8559000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-19430000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-16674000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
404000 usd
CY2021Q4 us-gaap Interest Expense
InterestExpense
409000 usd
us-gaap Interest Expense
InterestExpense
810000 usd
us-gaap Interest Expense
InterestExpense
819000 usd
CY2022Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
1093000 usd
CY2021Q4 us-gaap Interest And Other Income
InterestAndOtherIncome
64000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
1751000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
107000 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
689000 usd
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-345000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
941000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-712000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7839000 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8904000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18489000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17386000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000 usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
199000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-7888000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-8967000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18519000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17585000 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39663565 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39663565 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39199593 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39199593 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39635293 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39635293 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39143533 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39143533 shares
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-7888000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-8967000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18519000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17585000 usd
CY2022Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
103000 usd
CY2021Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-52000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
106000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-69000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7787000 usd
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9019000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18421000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17654000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
249480000 usd
CY2022Q3 csii Stock Based Compensation Restricted Stock Awards Net
StockBasedCompensationRestrictedStockAwardsNet
4324000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1191000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
174000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10631000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
242153000 usd
CY2022Q4 csii Stock Based Compensation Restricted Stock Awards Net
StockBasedCompensationRestrictedStockAwardsNet
3547000 usd
CY2022Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
23000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1499000 usd
CY2022Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
103000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-7888000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
239389000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
270958000 usd
CY2021Q3 csii Stock Based Compensation Restricted Stock Awards Net
StockBasedCompensationRestrictedStockAwardsNet
5523000 usd
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4990000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
324000 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-17000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-8618000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
263192000 usd
CY2021Q4 csii Stock Based Compensation Restricted Stock Awards Net
StockBasedCompensationRestrictedStockAwardsNet
3659000 usd
CY2021Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
161000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1854000 usd
CY2021Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-52000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-8967000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
259525000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18519000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17585000 usd
us-gaap Depreciation
Depreciation
1797000 usd
us-gaap Depreciation
Depreciation
1895000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
691000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
650000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7985000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9912000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
50000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
615000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-800000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-69000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-26000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
612000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5089000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6624000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-642000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
278000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-950000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2667000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1525000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-5456000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-11996000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1783000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1121000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17200000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12315000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2727000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2426000 usd
csii Payments To Acquire Intangible Assets Purchased
PaymentsToAcquireIntangibleAssetsPurchased
1700000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
8540000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
8999000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
52523000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
50844000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
14389000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
6817000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
59875000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
68261000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10474000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11109000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1499000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1242000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1214000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5151000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-140000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-102000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
145000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3999000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6581000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5205000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66424000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71070000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59843000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65865000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
41504000 usd
CY2022Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
40974000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1272000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1296000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40232000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39678000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
16340000 usd
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13780000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2404000 usd
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2785000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
22447000 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
18002000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
41191000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
34567000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3313000 usd
CY2022Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4128000 usd
CY2022Q4 us-gaap Land
Land
572000 usd
CY2022Q2 us-gaap Land
Land
572000 usd
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
22420000 usd
CY2022Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
22420000 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
25400000 usd
CY2022Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
24340000 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
3376000 usd
CY2022Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
3376000 usd
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
812000 usd
CY2022Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
812000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
4376000 usd
CY2022Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
2670000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
56956000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54190000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26954000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25155000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30002000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29035000 usd
CY2022Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
6513000 usd
CY2022Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
8104000 usd
CY2022Q4 csii Accrued Salaries And Bonus
AccruedSalariesAndBonus
5675000 usd
CY2022Q2 csii Accrued Salaries And Bonus
AccruedSalariesAndBonus
8082000 usd
CY2022Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2336000 usd
CY2022Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2345000 usd
CY2022Q4 csii Accrued Taxes
AccruedTaxes
847000 usd
CY2022Q2 csii Accrued Taxes
AccruedTaxes
953000 usd
CY2022Q4 csii Accrued Clinical Studies
AccruedClinicalStudies
1009000 usd
CY2022Q2 csii Accrued Clinical Studies
AccruedClinicalStudies
1082000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2769000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2898000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19149000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23464000 usd
CY2022Q4 csii Accrued Acquisition Consideration
AccruedAcquisitionConsideration
10000000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61453000 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59135000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121126000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117505000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61453000 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59135000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121126000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117505000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
991000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1315000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19950000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4907000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15043000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19950000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4216000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15734000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
690000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1377000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1374000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1373000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1371000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
8858000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15043000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
69688000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
88375000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
2331000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
4810000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
12503000 usd
CY2022Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
12333000 usd
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 usd
CY2022Q4 csii Future Payments To Acquire Longterm Investments
FuturePaymentsToAcquireLongtermInvestments
1200000 usd
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
20982000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
269000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
258000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
29000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
54000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1636000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1852000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
522000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
526000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1114000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1326000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1636000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1852000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
270000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
514000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
503000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
416000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1707000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
71000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1636000 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0255
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-7888000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-8967000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18519000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17585000 usd
CY2022Q4 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2021Q4 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2022Q4 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
-7888000 usd
CY2021Q4 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
-8967000 usd
us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
-18519000 usd
us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
-17585000 usd
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39663565 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39199593 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39635293 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39143533 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39663565 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39199593 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39635293 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39143533 shares
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45

Files In Submission

Name View Source Status
0001180145-23-000016-index-headers.html Edgar Link pending
0001180145-23-000016-index.html Edgar Link pending
0001180145-23-000016.txt Edgar Link pending
0001180145-23-000016-xbrl.zip Edgar Link pending
a10-qex311q2fy23.htm Edgar Link pending
a10-qex312q2fy23.htm Edgar Link pending
a10-qex321q2fy23.htm Edgar Link pending
a10-qex322q2fy23.htm Edgar Link pending
aex101csixcvtloanagreement.htm Edgar Link pending
aex102csivitessefirstamend.htm Edgar Link pending
aex103csiprojectvitessedev.htm Edgar Link pending
csii-20221231.htm Edgar Link pending
csii-20221231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
csii-20221231_cal.xml Edgar Link unprocessable
csii-20221231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
csii-20221231_lab.xml Edgar Link unprocessable
csii-20221231_pre.xml Edgar Link unprocessable
csii-20221231_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending